Cure8 research brief
The study points to a specific microbiome-derived micronutrient pathway (queuosine/queuine) that appears reduced in IBD, which could help explain part of microbiome-related changes in intestinal cells and suggest new biomarker or mechanistic targets.
Researchers (microbiome, metabolomics, tRNA biology), translational clinicians, and informed adult IBD patients interested in microbiome research.
This preprint reports a multi-omics re-analysis of public datasets suggesting that genes and bacterial taxa responsible for queuosine (q) biosynthesis are reduced in people with IBD versus healthy controls.
The authors integrate shotgun metagenomes, single-cell RNA-seq, and metabolic data to identify q-producing bacteria (examples highlighted include Bacteroides, Alistipes, Akkermansia) and show lower expression of the host tRNA-modifying enzyme QTRT1 in intestinal epithelial cells from IBD patients.
The study is a bioinformatic secondary analysis (not a prospective clinical trial or intervention). It defines a “functional dysbiosis” focused on microbial queuosine pathways rather than testing queuine supplementation or clinical outcomes.
The work may generate hypotheses about a microbiome-dependent micronutrient pathway that could influence host cell biology in IBD. Because this is a medRxiv preprint, findings have not completed peer review and should be considered preliminary. The paper supports further experimental and clinical work rather than immediate changes in care.
Preprint on medRxiv and based on secondary bioinformatic analyses of public datasets; results are associative and have not been peer reviewed. The study does not test interventions or clinical outcomes.
Review the original publication for the complete reporting, methods, and context.
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
The study describes a mechanism by which Huaier granules reduced colitis-related inflammation in mice and cell models by targeting macrophage cGAS–STING signaling and altering the gut microbiome—information that could...
If you or someone you care for is not responding to anti‑TNF drugs for ulcerative colitis, this review explains biological reasons why that may happen and points toward research directions that could lead to better tests...
Phosphatidylcholines are implicated in IBD biology; identifying a gene that regulates PC metabolism could point to new mechanistic targets. If PRKAB1 modulates epithelial lipid metabolism relevant to inflammation, it may...
